DOI: https://doi.org/10.26641/1997-9665.2020.3.70-75
Особливості патоморфологічної діагностики аденозу передміхурової залози та презентація клінічного випадку
Анотація
Ключові слова
Повний текст:
PDF (English)Посилання
Pospishil YO, Servetnyk MI, Artyshchuk MF. [Clinical case of primary squamous cell carcinoma of prostate gland]. Patologiya. 2010;7(2):113-15.Ukrainian.
Servetnyk MI, Pospishil YO. [Prostate gland carcinoma: correlations between PSA-level, patient age, stage of tumor growth and Gleason differentiation grade system]. Acta Medica Leopoliensia, Lvivskyi medychnyi chasopys. 2010;16(2):52-57.Ukrainian.
Servetnyk MI, Pospishil YO. [Сlinical and morphological characteristics of prostate intraepithelial neoplasia]. Patologiya. 2011;8(3):30-34. Ukrainian.
Armah HB, Parwani AV. [Atypical adenomatous hyperplasia (adenosis) of the prostate: a case report with review of the literature]. Diagnostic Pathology. 2008; (3):345–54.
Cheng L, Shan A, Cheville JC, Quian J, Bostwick DG. [Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?]. Cancer Research. 1998;58(3): 389–91.
Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH, Bose D, Harrison J, Young RH. [Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma]. Human Pathology. 1993;24(8):819–32. DOI: 10.1016/0046-8177(93)90131-y.
Baydar DE. [Adenosis (Atypical Adenomatous Hyperplasia) of Prostate]. Journal of Urological Surgery. 2015;1:53–54. DOI: 10.4274/jus.2015.01.018.
Bostwick DG, Qian J. [Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies]. American Journal of Surgical Pathology. 1995;19:506–18.DOI: 10.1097/00000478-199505000-00002.
Epstein JI, Netto GJ, authors; Shaw R, editor. Biopsy Interpretation of Prostate. 5th edition. Philadelphia (USA): Wolters Kluwer Health; 2015. 425 p.
Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z. [Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate]. American Journal of Surgical Pathology. 2002;26(7): 921–5. DOI: 10.1097/00000478-200207000-00011.
Gaudin PB, Epstein JI. [Adenosis of the prostate. Histologic features in needle biopsy specimens]. American Journal of Surgical Pathology. 1995;19:737–47. DOI: 10.1097/00000478-199507000-00001.
Doll JA, Zhu X, Furman J, Kaleem Z, Torres C, Humphrey PA, Donis-Keller H. [Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis)]. American Journal of Pathology.1999;155(3):967–71.DOI: 10.1016/S0002-9440(10)65196-6
Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumours 3. Lyon: IARC Press; 2004. 353 p.
Buhmeida A, Pyrhonen S, Laato M, Collan Y. [Prognostic factors in prostate cancer]. Diagnostic Pathology. 2006;1:74–82. DOI:10.1186/1746-1596-1-4.
Qian J, Jenkins RB, Bostwick DG. [Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization]. Urology. 1995;46:837–42. DOI:10.1016/S0090-4295(99)80354-9.
Hansel DE, Herawi M, Montgomery E, Epstein JI. [Spindle cell lesions of the adult prostate]. Modern Pathology. 2007;20:148–58. doi:10.1038/modpathol.3800676.
Thompson EW, Newgreen DF, Tarin D. [Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?]. Cancer Research. 2005;65(14):5991–95. doi: 10.1158/0008-5472.CAN-05-0616.
Trpkov K. [Benign mimics of prostatic adenocarcinoma]. Modern Pathology. 2018;31:22-46.
Morphologia